This is a preview of subscription content, log in via an institution to check access.
Notes
The study was affiliated with, and funded by, Galerma Pharmaceuticals.
Reference
Whang KA, et al. Health-related quality of life and economic burden of prurigo nodularis. . Journal of the American Academy of Dermatology : 28 May 2021. Available from: URL: http://doi.org/10.1016/j.jaad.2021.05.036
Rights and permissions
About this article
Cite this article
Prurigo nodularis associated with significant QOL impairment and costs in the USA. PharmacoEcon Outcomes News 880, 24 (2021). https://doi.org/10.1007/s40274-021-7782-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7782-0